Characterizing the 3-year course of cannabis involvement in NESARC Cannabis is the most commonly used illegal psychoactive substance in the United States and in developed nations. For instance, in the U.S., over 40 percent of 12th graders reporting a lifetime history of cannabis use. Cannabis abuse/dependence, the rate of which had increased by 18 percent in the past decade, is associated with several aspects of cognitive difficulty, comorbid substance use and psychopathology and aero-respiratory problems, making cannabis involvement a growing public health concern. Despite being a potent correlate of externalizing and internalizing disorders particularly in trajectories of alcohol, tobacco and other illegal drug use, little is know of the influences on changes in an individual's level of cannabis involvement. Why do some individuals remain occasional users while others progress to heavier and even problem use or abuse and dependence? Additionally, why do some individuals cease use while others continue, or even relapse after short-term cessation? A challenge in this area of research has been the lack of longitudinal data that is both rich in assessments of cannabis involvement and its correlates and adequately sized to allow for a dissection of the various stages of cannabis involvement. This small budget secondary data analysis R03 proposes to utilize a nationally representative U.S. sample of 43,093 adults, 34,653 of whom participated in two waves of interviews, across a 3-year follow-up period to: (a) identify groups of individuals whose cannabis involvement changes (either progression or desistence) across the 3-year follow up (i.e. movers) and groups where cannabis involvement remains stable (i.e. stayers), and (b) using predictors and correlates from socio- demographic, childhood, social/contextual, co-occurring substance use, psychopathology, negative and positive life events and treatment-related, to characterize the various transitions in cannabis involvement, ranging from non-use to occasional use (and its reverse) to change from dependence to cessation. We hypothesize that socio-demographic, early childhood and the social/contextual domains will play a more prominent role in the earlier transitions (e.g. initiation of use) while stress, psychopathology and co-occurring substance use will exert a more potent influence on later transitions (e.g. from regular use to dependence). A combination of latent variable mixture modeling (e.g. latent class and mover stayer models), survival and event history analyses and propensity score analyses will allow us to define and characterize the various changes in cannabis involvement. The results from our analyses will be valuable in designing targeted interventions, based on constellations of risk and protective influences, for a particular level of cannabis involvement. The use of existing data, on which our team publishes extensively using sophisticated statistical methodology, and the shorter project duration, provides a cost-effective approach to improving our comprehension of the process of cannabis involvement.

Public Health Relevance

This project proposes to outline change in cannabis involvement in a nationally representative sample of U.S. adults, and to characterize the risk and protective influences that are associated with these transitions in cannabis involvement. Results from this study may be useful in designing targeted interventions for cannabis involvement.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Small Research Grants (R03)
Project #
5R03DA025886-02
Application #
7826627
Study Section
Behavioral Genetics and Epidemiology Study Section (BGES)
Program Officer
Weinberg, Naimah Z
Project Start
2009-05-15
Project End
2012-04-30
Budget Start
2010-05-01
Budget End
2012-04-30
Support Year
2
Fiscal Year
2010
Total Cost
$76,000
Indirect Cost
Name
Washington University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
De Alwis, Duneesha; Lynskey, Michael T; Reiersen, Angela M et al. (2014) Attention-deficit/hyperactivity disorder subtypes and substance use and use disorders in NESARC. Addict Behav 39:1278-85
Agrawal, Arpana; Lynskey, Michael T (2014) Have the genetics of cannabis involvement gone to pot? Nebr Symp Motiv 61:71-108
Sartor, C E; Agrawal, A; Lynskey, M T et al. (2013) Cannabis or alcohol first? Differences by ethnicity and in risk for rapid progression to cannabis-related problems in women. Psychol Med 43:813-23
Derringer, Jaime; Krueger, Robert F; Dick, Danielle M et al. (2013) Measurement invariance of DSM-IV alcohol, marijuana and cocaine dependence between community-sampled and clinically overselected studies. Addiction 108:1767-76
Agrawal, A; Verweij, K J H; Gillespie, N A et al. (2012) The genetics of addiction-a translational perspective. Transl Psychiatry 2:e140
Agrawal, Arpana; Nelson, Elliot C; Littlefield, Andrew K et al. (2012) Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression. Arch Gen Psychiatry 69:732-40
Agrawal, Arpana; Budney, Alan J; Lynskey, Michael T (2012) The co-occurring use and misuse of cannabis and tobacco: a review. Addiction 107:1221-33
Agrawal, Arpana; Bierut, Laura J (2012) Identifying genetic variation for alcohol dependence. Alcohol Res 34:274-81
Duncan, Alexis E; Agrawal, Arpana; Bucholz, Kathleen K et al. (2011) Deconstructing the architecture of alcohol abuse and dependence symptoms in a community sample of late adolescent and emerging adult women: an item response approach. Drug Alcohol Depend 116:222-7
McCutcheon, Vivia V; Agrawal, Arpana; Heath, Andrew C et al. (2011) Functioning of alcohol use disorder criteria among men and women with arrests for driving under the influence of alcohol. Alcohol Clin Exp Res 35:1985-93

Showing the most recent 10 out of 16 publications